News & Updates from McGivney Global

McGivney Global

Oncologists, McGivney Weigh in on Value Frameworks

Prior to the ICER meeting to review evidence and vote on cost-effectiveness ratings for NSCLC treatments, five prominent oncologists...

McGivney Global

Comments on the Recent Institute for Clinical and Economic Review (ICER) Meeting

I have extensive experience in “real world” policy-setting and decision-making and I am puzzled about the motivations regarding the...

McGivney Global

Impact of Oncology Value Metrics

McGivney Global Advisors publishes quarterly reports assessing the changes and impact of Oncology Value Metrics, including NCCN Evidence...

McGivney Global

Health Insurers Behaving Badly...

Will a spate of recent lawsuits shift the balance of power in the health care industry? While no companies in the health care industry...

McGivney Global

McGA work on ICER cited by BIO

A McGivney Global Advisors op-ed on Oncology Value Metrics and ICER was referenced by the Biotechnology Industry Organization, quoting...

McGIVNEY